Filing search / Phathom Pharmaceuticals, Inc. / "Leadership"

8-K

EX-99.1

xyp3rms tvhsg

9 Nov 23

Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates

8:05am

PRE 14A

5j05no54jfo

31 Mar 23

Preliminary proxy

4:06pm

8-K

EX-99.1

q7xclszpif69d4jyzwz

9 Nov 22

Phathom Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Updates

8:06am

8-K

EX-99.1

lml fzgq0vw5

10 May 22

Phathom Pharmaceuticals Reports First Quarter 2022 Results and Provides Recent

8:06am

8-K

EX-99.1

0m5ahhxsif2dagwl3pu8

6 Aug 20

Phathom Pharmaceuticals Reports Second Quarter 2020 Results

8:35am

8-K

tvo46p0moz7f80wdjfc

13 Jul 20

Departure of Directors or Certain Officers

8:36am

DEF 14A

os9rtyyy

8 Apr 20

Definitive proxy

8:31am

8-K

EX-99.1

jjiyhl4965ov

19 Mar 20

Phathom Reports Fourth Quarter and Full Year 2019 Financial

8:36am

8-K

l7deaoyeavczcnu0 goi

2 Dec 19

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:30pm